The second pandemic of "Asiatic cholera" 2 (also known as "spasmodic cholera" 2 , "blue cholera" 3 , or "cholera asphyxia" 2 ) originated in India, in 1826 4 . This "pestilential disease of strange and overwhelming malignancy" 5 spread along the trade routes of Asia and Europe 4 , before arriving in Sunderland, England, in October 1831 1 . Neither the cause nor the definitive management of the condition were known, and physicians were forced to choose empirically from a range of uncertain, often paradoxical treatments. These included the administration of sedatives, or stimulants, and the application of warmth, or cold 5 . Few of the suggested remedies had any rational basis, and most proved worthless. Some were "positively injurious" 5 .
Bloodletting established itself as the mainstay of treatment for the advanced stage of cholera, in which the skin appeared blue. The arteries of such patients were found to contain thick, black blood. This was believed to result from venous stagnation, combined with a "rapid cessation of arterialisation" 3 . Bleeding was seen as "a means of diminishing the venous congestion… thus restoring the suspended circulation, and… recovering the arterial qualities of the blood, of which a bright scarlet hue is an outward and visible sign" 3 . Others postulated that similar changes could be effected by the inhalation of oxygen, mixtures of oxygen and air, or nitrous oxide 3 .
On 3 December 1831, William O'Shaughnessy read a paper before the Westminster Medical Society in which he proposed the intravenous injection of "highly-oxygenised salts" (potassium nitrate or chlorate) as an alternative means of restoring the arterial qualities of the blood in cases where venesection proved impossible, or "the violence of the malady derides all others means of medication" 3 .
O'Shaughnessy was aware of in vitro data presented 19 months earlier by William Stevens, in which "neutral salts" had been added to the blood of victims of yellow fever 6 . Although the results appeared promising, and the blood immediately changed "from black, to a colour that was highly arterial", Stevens restricted himself to the enteral administration of saline in his clinical practice.
While some of his contemporaries called for a trial of intravenous sodium chloride in late 1831 7, 8 , O'Shaughnessy dismissed the idea, stating "chloride of sodium, though it does redden venous blood, cannot possibly oxygenate it, as it contains no oxygen itself" 3 .
Within a fortnight of presenting his paper in London, O'Shaughnessy travelled to Sunderland to directly acquaint himself with the cholera epidemic 1 . In the first seven weeks of the outbreak, a total of 449 cases, including 155 deaths, were recorded in the city 1 . By 7 December 1831, the disease had spread to neighbouring Newcastle Upon Tyne 1 , where O'Shaughnessy undertook a series of detailed experiments examining the blood of victims. This pivotal work demonstrated that blood from the worst cases "was unchanged in its anatomical or globular structure" 9 but had "lost a large proportion of its water... and neutral saline ingredients" 9 .
In a report presented to the Central Board of Health on 7 January 1832, O'Shaughnessy outlined two new goals in the management of cholera: "First. To restore the blood to its natural specific gravity. Second. To restore its deficient saline matters" 10 . He noted "the first of these can only be effected by absorption, by imbibition, or by the injection of aqueous fluid into the veins. The same remarks, with sufficiently obvious modifications, apply to the second" 10 .
O'Shaughnessy immediately abandoned his theory of injecting highly-oxygenised salts in advanced cases of cholera, recommending instead that these individuals receive "some ounces of warm water into the veins" 10, 11 . He advised dissolving "the mild innocuous salts which nature herself is accustomed to combine with the human blood", within the injectate 10 .
Reports outlining the clinical application of O'Shaughnessy's suggestions were published from May 1832, onwards 4, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Image courtesy of the Wellcome Library, London.
The first documented case was that of an "aged female", under the care of Thomas Latta, in Leith, Scotland 12, 13 . In common with others receiving intravenous saline during this outbreak [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , the woman had exhausted all the usual remedies, and deteriorated into a seemingly hopeless state of collapse 13 . Indeed, Latta feared he might be unable to dissolve the salt solution (consisting of two to three drachms of muriate of soda and two scruples of subcarbonate of soda, in a total of six pints of water), and assemble his apparatus (Read's patent syringe 12 ), before she expired 13 . Fortunately, these concerns proved unfounded, and after inserting a tube into the basilic vein, Latta proceeded to inject the salt solution, warmed to 112°F. Soon after, the patient "began to glow with returning animation; the pulse, which had long ceased, returned to the wrist… and in the short space of half an hour, when six pints had been injected, she expressed in a firm voice that she was free from all uneasiness, actually became jocular, and fancied all she needed was a little sleep" 13 . Sadly, these miraculous benefits were short-lived, and, in what became a common occurrence in these cases [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , severe vomiting and diarrhoea returned, and the patient died.
Intravenous injection also carried with it the risks of thrombophlebitis 23 , venous air embolism 13 , and the introduction of so much fluid as to cause "constitutional injury" 25 . Physicians at the Cholera Hospital, Westminster, observed several cases in which stertorous breathing, signs of cerebral oedema and coma followed the administration of large volumes of saline 22 .
Given the preponderance of comorbidities among those commonly afflicted by cholera ("the weak… the destitute… and the dissipated" 4 ), as well as the moribund state of patients immediately prior to commencement of intravenous therapy, it is of no surprise that the injection of saline was associated with an extremely high mortality during the 1832 cholera outbreak in Great Britain 4,12-24 . In the aftermath, there was much reflection on the utility of this treatment, and while some were dismissive 26 , others believed that intravenous saline might prove useful, "if adopted before the patient reaches too collapsed a state" 27 .
